Susan Weng Larsen

Susan Weng Larsen

Associate Professor, Guest Researcher

ORCID: 0000-0002-3818-7275

Publication year:
All
51 - 60 out of 72Page size: 10
Sort by: 1st author
  1. Published

    In situ formed suspensions for local sustained action of celecoxib following intra-articular administration

    Larsen, Susan Weng, Frost, A. B., Østergaard, Jesper, Jacobsen, Stine, Thomsen, M. H., Lindegaard, Casper, Andersen, P. H. & Larsen, C. S., 2009. 2 p.

    Research output: Contribution to conference › Poster › Research

  2. Published

    Medicindepot dannes efter injektion i leddet

    Larsen, Susan Weng, Thing, M. A., Østergaard, Jesper, Kristensen, Jesper Langgaard, Hansen, M. & Larsen, C. S., 2013, In: Lægemiddelforskning. 2013, p. 38-40

    Research output: Contribution to journal › Journal article › Research

  3. Published

    IMIDAZOLE DERIVATIVES AS PRODRUGS OF DICLOFENAC

    Larsen, C. S., Larsen, Susan Weng, Thing, M. A., Kristensen, Jesper Langgaard, JENSEN, H. & Østergaard, Jesper, 6 May 2016, IPC No. A61P 29/ 00 A I, Patent No. WO2016066612, Priority date 28 Oct 2014, Priority No. DK20140070657

    Research output: Patent

  4. Published

    Controlled release - macromolecular prodrugs

    Larsen, C. S., Østergaard, Jesper & Larsen, Susan Weng, 2007, Prodrugs: challenges and rewards. Stella, V. J., Borchardt, R. T., Hageman, M. J., Oliyai, R., Maag, H. & Tilley, J. W. (eds.). New York: Springer, p. 379-416

    Research output: Chapter in Book/Report/Conference proceeding › Book chapter › Research

  5. Published

    Intra-articular depot formulation principles: role in the management of postoperative pain and arthritic disorders

    Larsen, C. S., Østergaard, Jesper, Larsen, Susan Weng, Jensen, H., Jacobsen, Stine, Lindegaard, Casper & Andersen, P. H., 2008, In: Journal of Pharmaceutical Sciences. 97, 11, p. 4622-4654 33 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  6. Published

    PRODRUGS OF NON- STEROID ANTI - INFLAMMATORY AGENTS (NSAIDS)

    Larsen, C. S., Larsen, Susan Weng, Thing, M. A., Kristensen, Jesper Langgaard, JENSEN, H. & Østergaard, Jesper, 10 May 2013, IPC No. C07D 487/ 04 A I, Patent No. WO2013064153, Priority date 31 Oct 2011, Priority No. DK20110070591

    Research output: Patent

  7. Published

    PRODRUGS OF NAPROXEN AND DICLOFENAC

    Larsen, C. S., Larsen, Susan Weng, Thing, M. A., Kristensen, Jesper Langgaard, JENSEN, H. & Østergaard, Jesper, 17 Mar 2016, IPC No. A61K 45/ 06 A I, Patent No. US2016074523, Priority date 28 Apr 2014, Priority No. WO2014EP58530

    Research output: Patent

  8. Published

    Role of in vitro release models in formulation development and quality control of parenteral depots

    Larsen, C. S., Larsen, Susan Weng, Jensen, H., Yaghmur, Anan & Østergaard, Jesper, 2009, In: Expert Opinion on Drug Delivery. 6, 12, p. 1283-1295

    Research output: Contribution to journal › Review › Research

  9. Published

    Role of in vitro release models in formulation development and quality control of parenteral depots

    Larsen, C., Larsen, Susan Weng, Yaghmur, Anan, Østergaard, Jesper & Jensen, H., Dec 2009, In: Expert Opinion on Drug Delivery. 6, 12, p. 1283-1295

    Research output: Contribution to journal › Journal article › Research › peer-review

  10. Published

    Physicochemical profiling of drug candidates using capillary-based techniques

    Jensen, H., Larsen, Susan Weng, Larsen, C. S. & Østergaard, Jesper, 2013, In: Journal of Drug Delivery Science and Technology. 23, p. 333-345

    Research output: Contribution to journal › Journal article › Research › peer-review

Previous 12 3 4 5 6 7 8 Next

ID: 1304281